/
Codes: j7633

j7633

j7633 is a valid HCPCS code for 2023. It's used to specify:
Budesonide inhalation solution fda-approved final product non-compounded administered through dme concentrated form per 0.25 milligram

j7633- HCPCS Details

HCPCS Code

j7633

Description

Short Description
Budesonide non-comp con
Long Description
Budesonide inhalation solution fda-approved final product non-compounded administered through dme concentrated form per 0.25 milligram

A code denoting Medicare coverage status.

HCPCS Coverage Code ⓘ

C

A code denoting the change made to a procedure or modifier code within the HCPCS system.

HCPCS Action Code ⓘ
N =
No maintenance for this code

Code used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.

HCPCS Pricing Indicator ⓘ
51 =
Drugs

Code used to identify instances where a procedure could be priced under multiple methodologies.

HCPCS Multiple Pricing Indicator Code ⓘ
A =
Not applicable as HCPCS priced under one methodology

Berenson-Eggers Type of Service (BETOS) classification categories are used to analyze Medicare costs. All Health Care Financing Administration Common Procedure Coding System (HCPCS) procedure codes are assigned to a BETOS category.

BETOS Classification ⓘ

D1G =
Drugs Administered through DME

The carrier assigned CMS type of service which describes the particular kind(s) of service represented by the procedure code.

Type of Service ⓘ

1 =
Medical care
( )

Effective date of action to a procedure or modifier code

Effective Date ⓘ

01/01/2007

The year the HCPCS code was added to the Healthcare Common Procedure Coding System.

Date Added ⓘ

01/01/2003
Termination Date
-

The HCPCS Code Section that this code belongs to. It's typically denoted by the first letter in the code.

Code Section ⓘ

j